Univasc Oral Tablet 15Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Univasc: Oral tablet (15mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_2502.JPG
Moexipril 15mg Tab
Teva Pharmaceuticals USA
Pill Identification: 93  |  5150
Drug Image file DrugItem_10928.JPG
Moexipril 15mg Tab
Teva Pharmaceuticals USA
Pill Identification: 93  |  5150
Drug Image file DrugItem_1722.JPG
Univasc 15mg Tab
UCB Pharma Inc
Pill Identification: SP 15  |  715
Drug Image file DrugItem_8696.JPG
Moexipril 15mg Tab
Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett Company. Inc.
Pill Identification: KU 15  |  177
Drug Image file DrugItem_10700.JPG
Moexipril 15mg Tab
Actavis US
Pill Identification: KU 15  |  177
Drug Image file DrugItem_25775.JPG
Moexipril 15mg Tab
Glenmark Pharmaceuticals
Pill Identification: G  |  208

What is this Medicine?

MOEXIPRIL (moe EX i pril) is an ACE inhibitor. This medicine is used to treat high blood pressure.

In-Depth Information

Univasc 15mg Tablet

NDC: 000913715
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Hypertension

Storage Information
Protect from moisture
Store at controlled room temperature (between 68 and 77 degrees F)
Univasc 15mg Tablet
Drug Image file DrugItem_1722.JPG
UCB Pharma Inc
Pill Identification: SP 15  |  715
Shape: round
Color: pink

Reported Side Effects for Univasc 15mg Tablet

Breathing Difficulties Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Dry Mouth Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Liver Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Heart Attack Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Inflamed Pancreas Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Brain Attack Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Vomiting Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Diaphoresis Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Metallic Taste Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Liver Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Death Of Liver Tissue Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Laryngeal Edema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Feeling Sick Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Kidney Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Constipation Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Drowsiness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Nervousness Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Shortness Of Breath Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Decreased Appetite Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Angioedema Incidence:
<0.5%*
Severity: SEVERE
Onset: RAPID
Hemolytic Anemia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Lung Inflammation Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Ringing In Ears Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Fainting Incidence:
0.5%*
Severity: MILD
Onset: EARLY
Low Blood Pressure Incidence:
0.5%*
Severity: MODERATE
Onset: RAPID
Postural Low Blood Pressure Incidence:
0.5%*
Severity: MODERATE
Onset: DELAYED
Sinus Infection Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Rhinitis Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Increased Urination Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
>1.0%*
Severity: MODERATE
Onset: EARLY
High Potassium Level Incidence:
1.3%*
Severity: SEVERE
Onset: DELAYED
Muscle Pain Incidence:
1.3%*
Severity: MILD
Onset: EARLY
Flushing Incidence:
1.6%*
Severity: MILD
Onset: RAPID
Skin Rash Incidence:
1.6%*
Severity: MILD
Onset: EARLY
Tired Incidence:
2.4%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
3.1%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
4.3%*
Severity: MILD
Onset: EARLY
Cough Incidence:
6.1%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
First Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Second Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Third Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Univasc

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5